Fundz

Real-time funding, M&A, exec moves & hiring — the signals that move deals

More real-time opportunities that match your ICP — every funding, M&A, and exec move the moment it breaks, with the verified contacts to reach out first.

The funding market, moving in real timeBook a DemoStart with Pro — $79/mo
Loading live signals…

Funding, M&A, exec moves & hiring — every signal Fundz sees, the moment it happens. See who’s in your market, who to reach, and why now.

Back to SEC Filings
Material AgreementItem 1.01 · 8-KMEDIUM RiskPositive

TRANSLATIONAL DEVELOPMENT ACQUISITION CORP.

Filed: May 27, 2026New York, New YorkCIK: 0001926599
Watch CompanyView on SEC.gov

AI Executive Summary

AI-powered analysis of 8-K filing content

Translational Development Acquisition Corp. entered into a Business Combination Agreement on May 27, 2026, marking a strategic expansion in the life sciences sector through acquisition of an undisclosed company.

Key Takeaways

Business Combination Agreement executed on May 27, 2026 with an unnamed acquiree in the life sciences sector

Transaction involves issuance of units consisting of one Class A ordinary share and one-half redeemable warrant exercisable at $11.50

2 more takeaways

Filing Overview

Form Type8-K
Filing DateMay 27, 2026
Item1.01
CategoryMaterial Agreement
CIK0001926599
Accession #0001926599
Risk LevelMEDIUM
SentimentPositive
Signalopportunity
Topics
acquisitionipo spac

What This Means

The company entered into a significant agreement that could materially affect its business. This often signals new partnerships, licensing deals, or major contracts.
View Full Filing on SEC.govBrowse More Filings